Half of patients in a trial have safely stopped immunosuppressant medication following a modified blood stem-cell transplant for severe sickle cell disease, according to a study in the Journal of the American Medical Association . The trial was conducted by researchers from NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung, and Blood Institute. The transplant done in … Continue reading Adults stop anti-rejection drugs after partial stem-cell transplant reverses sickle cell disease.